Want to see KR:302440 full AI Analyst Report?
SK bioscience Co.,Ltd. (302440) Income Statement
SK bioscience Co.,Ltd. Income Statement
Last quarter (Q2 2026), SK bioscience Co.,Ltd.'s total revenue was $155.71B, a decrease of 3.80% from the same quarter last year. In Q2, SK bioscience Co.,Ltd.'s net income was $-14.09B. See SK bioscience Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 651.37B | $ 267.55B | $ 369.51B | $ 456.73B | $ 929.00B | |
| $ 59.49B | $ 30.98B | $ 141.82B | $ 239.61B | $ 570.28B | |
| $ 210.81B | $ 169.41B | $ 146.56B | $ 124.60B | $ 96.06B | |
| Depreciation and Amortization | $ 91.02B | $ 49.23B | $ 34.76B | $ 27.24B | $ 18.78B |
| $ -60.31B | $ -36.20B | $ 43.49B | $ 171.43B | $ 493.00B | |
| $ -151.33B | $ -138.43B | $ -4.73B | $ 115.01B | $ 474.22B | |
| $ 65.47B | $ 49.32B | $ 12.06B | $ 26.72B | $ -3.09B | |
| $ -85.86B | $ -89.11B | $ 7.33B | $ 141.73B | $ 471.13B | |
| $ -56.17B | $ -53.88B | $ 22.32B | $ 122.45B | $ 355.14B | |
| Per Share Metrics | |||||
| Basic EPS | $ -718.26 | $ -700.16 | $ 291.00 | $ 1596.18 | $ 4642.34 |
| Diluted EPS | $ -718.26 | $ -701.32 | $ 289.79 | $ 1589.84 | $ 4642.34 |
| Weighted Average Shares Outstanding | 78.21M | 77.20M | 76.69M | 76.72M | 76.50M |
| Weighted Average Shares Outstanding (Diluted) | 78.21M | 77.39M | 77.01M | 77.02M | 76.50M |
Currency in KRW
